Testimony and Comments

IPO Comments on Joint USPTO–FDA Collaboration Initiatives

By Hannah Denny|2023-02-07T07:47:25-05:00February 6th, 2023|Testimony and Comments|Comments Off

IPO Comments Regarding USPTO Initiatives To Ensure the Robustness and [...]

By Hannah Denny|2023-02-07T07:45:18-05:00February 1st, 2023|Testimony and Comments|Comments Off

IPO Comments Regarding Expanding Opportunities to Appear Before the Patent [...]

By Hannah Denny|2023-02-01T13:35:58-05:00January 31st, 2023|Testimony and Comments|Comments Off

IPO Comments Regarding Expanding Admission Criteria for Registration to Practice [...]

By Hannah Denny|2023-02-01T13:33:59-05:00January 31st, 2023|Testimony and Comments|Comments Off

By Hannah Denny|2023-01-31T13:30:28-05:00January 30th, 2023|Testimony and Comments|Comments Off

By Hannah Denny|2023-02-27T10:47:53-05:00January 5th, 2023|Testimony and Comments|Comments Off

By Hannah Denny|2023-01-09T13:32:12-05:00December 14th, 2022|Testimony and Comments|Comments Off

By Hannah Denny|2022-11-01T09:53:05-04:00October 19th, 2022|Testimony and Comments|Comments Off

By Hannah Denny|2022-11-01T09:47:28-04:00October 15th, 2022|Testimony and Comments|Comments Off

By Hannah Denny|2022-10-11T11:14:45-04:00October 7th, 2022|Testimony and Comments|Comments Off